MarketPeel
Insider Trading Intelligence
Pricing
…
DS

Daniel J. Starks

ABT
DIRECTOR · ABBOTT LABORATORIES · CIK 0000902132
FILING MIX · LIFETIME52%/48%
BUYS
14
SELLS
13
TOTAL VALUE
$33.95M
COMPANIES
1
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
6,751,103
AVG SELL PX
$106.44
TRADE KIND
SHOWING 27 / 27
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
16 backtested trades · 8 horizons · 10 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Daniel J. Starks, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d16+81.25%-1.24%+0.06%-1.29%-1.14%—
14d16+62.50%-0.12%+1.43%-1.55%-1.75%—
30d16+50.00%+0.79%+2.91%-1.63%-0.90%—
60d16+62.50%-0.42%+0.07%-0.49%-1.48%—
90d16(1 pending)+60.00%-2.25%+3.98%-6.23%-6.80%—
180d16(3 pending)+38.46%+0.12%+5.35%-5.23%-4.73%—
1y16(3 pending)+46.15%+1.79%+17.77%-15.98%-13.99%—
2y16(3 pending)+38.46%+11.19%+44.27%-33.08%-31.79%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABT · 6,751,103 shares · as of Apr 27, 2026
01,755,8753,511,7505,267,6257,023,500202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 14 buys / 13 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABT
ABBOTT LABORATORIES
PURCHASE
10,000$92.65$926.5K6,751,103Apr 27, 2026Apr 28, 2026 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
7,105——7,105Apr 24, 2026Apr 28, 2026 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
2,286——6,741,103Apr 24, 2026Apr 28, 2026 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASE
4,967$109.14$542.1K6,733,784Feb 4, 2026Feb 6, 2026 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASE
5,033$108.33$545.2K6,738,817Feb 4, 2026Feb 6, 2026 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
4,516——4,516Apr 25, 2025Apr 29, 2025 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
1,635——6,728,817Apr 25, 2025Apr 29, 2025 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
1,866——6,727,182Apr 26, 2024Apr 30, 2024 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
5,277——5,277Apr 26, 2024Apr 30, 2024 ↗View →
ABT
ABBOTT LABORATORIES
SALE10b5-1
10b5-1 plan
26,907$93.81$2.52M6,748,409Oct 26, 2023Oct 30, 2023 ↗View →
ABT
ABBOTT LABORATORIES
SALE10b5-1
10b5-1 plan
23,093$94.33$2.18M6,725,316Oct 26, 2023Oct 30, 2023 ↗View →
ABT
ABBOTT LABORATORIES
SALE10b5-1
10b5-1 plan
29,066$114.01$3.31M6,775,316Jul 27, 2023Jul 28, 2023 ↗View →
ABT
ABBOTT LABORATORIES
SALE10b5-1
10b5-1 plan
20,934$113.43$2.37M6,804,382Jul 27, 2023Jul 28, 2023 ↗View →
ABT
ABBOTT LABORATORIES
SALE
3,452$111.75$385.8K6,825,316May 2, 2023May 2, 2023 ↗View →
ABT
ABBOTT LABORATORIES
SALE
46,548$110.97$5.17M6,828,768May 2, 2023May 2, 2023 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
1,816——6,875,316Apr 28, 2023May 2, 2023 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
8,136——8,136Apr 28, 2023May 2, 2023 ↗View →
ABT
ABBOTT LABORATORIES
SALE
40,687$97.30$3.96M6,882,813Oct 27, 2022Oct 31, 2022 ↗View →
ABT
ABBOTT LABORATORIES
SALE
9,313$98.14$913.9K6,873,500Oct 27, 2022Oct 31, 2022 ↗View →
ABT
ABBOTT LABORATORIES
SALE
27,749$108.77$3.02M6,945,751Jul 26, 2022Jul 28, 2022 ↗View →
ABT
ABBOTT LABORATORIES
SALE
22,251$109.60$2.44M6,923,500Jul 26, 2022Jul 28, 2022 ↗View →
ABT
ABBOTT LABORATORIES
SALE
16,822$112.51$1.89M7,006,678May 3, 2022May 5, 2022 ↗View →
ABT
ABBOTT LABORATORIES
SALE
27,055$113.29$3.07M6,979,623May 3, 2022May 5, 2022 ↗View →
ABT
ABBOTT LABORATORIES
SALE
6,123$114.84$703.2K6,973,500May 3, 2022May 5, 2022 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
1,602——7,023,500Apr 29, 2022May 3, 2022 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
1,499——7,021,898Apr 23, 2021Apr 27, 2021 ↗View →
ABT
ABBOTT LABORATORIES
PURCHASEGRANT
Stock grant
1,974——7,020,399Apr 24, 2020Apr 28, 2020 ↗View →
Other insiders · ABT
Loading peer insiders…
About this filer
CIK 0000902132
ROLE
Director
PRIMARY
ABT
COMPANIES
1
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0000902132DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback